qddusj |
2007-04-19 16:03 |
µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ
µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æרҵ£º ,3FG' q2 [p&2k&.XYe ´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ C9"yu&l a
qIpO Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) b?%Pa\,! WTQd}f 1. ICAM-1 -JfO} DRI 73>Hzpv0 2. interleukin 12(IL-12) !DNk!]| -x2&IJ! 3. tumor infiltrating lymphocyte t[Ywp!y[ xmbFJUMH 4. TCR/CD3 complex EK<ly"S. ?D S|vCae 5. hematopoietin receptor family hxx`f-#= dEG
1[QG 6. individual idiotype(IdI) T +~
_D YKG}4{T 7. integrin px=r~8M9} d2[R{eNX= 8. colony-stimulatory factor (CSF) Tl
`HFZQ1 {BS`v5* ¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© /eNDv(g)M GMQKR,6VM 1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? gWpG-RL0
A,#a?O6m 2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ {2MS,Ua{ 31=vUS
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ%r >Y)@$Vt N4[^!}4 4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØϵ¡£ `as6IMqJD T@x_}a:g Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) ;LE9w^>^V 4oA9|}<FR 1. ÊÔÊö¸ÉÈÅËصķÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌص㡣Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËؼì²âµÄ·½·¨ºÍÔÀí¡£ `g!NFp9q >^ijj`{d 2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ä¿Ç°¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) z`KP
}- pA?2UZ 3. immunoglobulin superfamily (IgSF) ?Q G?F9? ,R2;oF_ 4. selectin [ %:%C]4 i*2l4 5. anti-idiotypic antibody (¦ÁId) r"\g6<RP u[~= a5:4 6. major histocompatibility complex(MHC) X>kW)c4{b ?2i\ERG? 7. immunotolerance z((9vi W
T f;:C] 8. biological reponse modifier(BRM) n+%tu"e 1J @43>u{ 9. immune reponse gene (Ir gene) 7zEpuw 0FG|s#Ig 10. reshaped antibody (or reconstituted antibody) h(MS>= gi5Ffvs$ ¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© =]<JkWSk (X( c.Jj 1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ 5B,HJax :Yy8Ie# 2. ϸ°û¶¾ÐÔTÁÜ°Íϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? F,>-+~L= A.@Af+ 3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ >S=,ype~G 7UA|G2Zr 4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? #7yy7Y5 |{JJ2c\W
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ kF o&! 8bP4 1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? 9a;8^?Ld%S =as\Tp#d 2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ Xsit4Ma >W7IWhm3 ¹©Ïû»¯ÄÚ¿ÆרҵÊÔÌ⣺ "Ir.1FN g1zX^^nd,V 1. Ä¿Ç°ÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? [*|QA9 #Y
'svn1H 2. Ä¿Ç°µ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ D|rcSa.M kx_PMpc µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æרҵ: |nTZ/MXbw X* Dt<i};v ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: [osm\w49 P 2^((c ÃâÒßѧ Yt%
E,U~g !ii'hwFm$ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© </B5^} j*05!j<' 1. CD8 )TFBb\f>v u]%>=N(^2 2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) !NfN16 [6Nw)r(a( 3. immunoglobulin fold(Ig fold) oI6o$C QC\][I> 4. cadherin (Ca-dependent cell adhesion moleculers) E?+MM0 &QQ8ut,; 5. idiotype-anti-idiotypic antibody immune network theory &^W91C?<6 r$Z_Kwe.|& 6. HLA class II antigen H!NyM}jsr aj:B+}1 7. complementarity-determining region (CDR) c#6g[TE@
G$"$k=[ 8. perforin(or pore-forming protein ,PFP) L)LW5%.6 *Tt*\ O 9. high affinity IL-2 receptor
`=h`:` $"/xi ` 10. artificial active immunization bf3Njma% r6Hdp ¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© %EooGHGF? .#]
V5g,
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠV~uH)IMkh7 i:ZL0nH- 2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 a3<.F&c+c vNhi5EU 3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ KnC;j-j {i7Wp$ug 4. ÊԱȽÏT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃ濹ԡ¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ ByrK|lVM0 |nN{XjNfP5 Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐÑ¡Ò»Ìâ,3¡¢4ÌâÖÐÑ¡Ò»Ìâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ä¿Ç°¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ y0d a8sd) D9;2w7v 2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? RN1q/H| cVt
MCgx 3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ G 1rsd #-_';Er\ 4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ ' {L5 3cH= :)UF# µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ S0\;FmLIc QQso<.d& ѧ¿Æרҵ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ "eq{_4dL brA\Fp^ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© hlpi-
oW` SO#NWa<0| 1. immunoglobulin gene rearrangement BitP?6KX 4L RrrW 2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) 3[g%T2&[
p&SxR}h 3. flow cytometry(FCM) _;G. QwHr uXX3I
E[ 4. carrier effect +*2 ]R~"M zI5#'<n 5. positive selection of T lymphocytes in thymus M]O
_L @l)HX'z0d 6. mouse TH1(Th1) and TH2(Th2) subsets w-%V9]J1 <
9JI@\> 7. perforin (pore-forming protein ,PFP) "@1e0`n
Q Yv?nw-HM 8. ADCC(antibody-dependent cell-mediated cytotoxicity) 9`P<|( >h^CC*&'pw 9. SH-2(src-homology region 2) LUGyc( h D#ZzhHHP 10. Ab2¦Â (internal image) i6L>,^Dg !^{0vFWE ¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© B?BB 00Tm]mMQX 1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? OAoTsqj6 \LYB% K} 2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? C-i9F%.. ~HWH2g 3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ97 Oi} f{
;L"*L 4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ =Q\z*.5j. =L,s6J8_' 5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ%gK@R3p >
-P UY Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) ;WydXQ}Q^ yQAW\0` ÃâÒßѧרҵ£º v:2*<; s(~tL-_ K 1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ =ttvC"4? K90wX1& 2. ÊԱȽÏÈËT¡¢BÁÜ°Íϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? :%_*C09 <ttrd%VW ´«È¾²¡Ñ§×¨Òµ£º $<;!F=%8 nK95v}p}Y 1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦ÄÜ¿É·¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ Ue:LKK1Gsr |p4D!M+$7 2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØϵ¡£ 4Ss4jUj r;>2L' Ïû»¯×¨Òµ£º v'0WE @u@N&{b5" 1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ l(irNKutgo T^z 2.¼òÊöճĤÏà¹ØÁÜ°ÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌص㡣·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? I_?+;<n 9i6z p' µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ x9DG87P~+ B=?m_4\$m Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© N7Kg52| !^[i"F:
G 1. Fas(CD95)/FasL 0mt lM( Q1Jw7R#?l 2. common chain of cytokine receptor Gy]ZYo( (+(YQ2 3 . TCR/CD3 complex 4!vovt{ =&_Y=>rA]0 4. negaive selection of thymocytes \!51I./Q/ c"wk
_# 5. artificial active immune 0:1[F!]'b E;o
"^[we 6. anti-idiotypic hL?"!
Qhc>,v) 7. IgSF |8{c|Qz ! %~P[;. 8. Integrin 3D}rxI8N PHxU6UPqy 9. chemokine -$2B!#]3 Jan~Rran 10. B7/CD28 4[XiD*
* ZRy'lW ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© w/oXFs&FK _{C
=d3 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ WSsX*L )c<X.4 2. ±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌص㡣 NMvNw?] UhX)?'J 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ `9`T,uJe q; ?Kmk 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆʵÑé·½°¸¿Ë¡´Ë»ùÒò¡£ 2:jWO_V@ E4cPCQyeH 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ 7L4~yazmK jU}iQM µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ K})w GlOSCJZ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© QFg{.F?3q> <- (n48 1. B7/CD28 >mW*K _~ s= bP@[Gj 2. Th1 subset MC~<jJ, vUR@P
- 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© TMG|"| SH5a&OVZhn 4. antibody affinity maturation DEQ7u`6 /4YxB, 5. AP-1 r!&}4lHYi '&!:5R5 9 6. single chain variable fragment£¨ScFv£© v
8B4%1NE miB+'n"zS 7. NK cell receptor o#QS: '| 2rWPqG4e 8. Zinkernagel-Doherty phenomenon PlRcrT"#w D}OhmOu3 9. Ig fold |.?Xov] fn,
YH 10. CD40/CD40L 6){nu rDBG <AN5>:k[pM ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© Hn}m}A 'B;n
&tJ
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØϵ¡£ YM&i t[p/65L>8 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ Gx;
-1 nP+jkNn3 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹Øϵ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ M~g{}_0Z 2Ft#S8 Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ >9,LN;Ic 3
p!t_y|SX 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁÜ°Íϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ D77s3AyHK TGZr
[ 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ w"q^8"j! """pe+Y 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æרҵ£©¡£ N=j$~,yG H`nd | Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ £¨ÃâÒßѧרҵºÍרҵ»ù´¡£© >"[Nmx0;w ->'xjD Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
rw#?NI: ]\F}-I[ 1.Co-stimulators (or co-stimulating molecules) -/R?D1kOq 9P*p{O{_ 2.NK-kB $9ys!
<g KeWIC,kq 3.Immunoglobulin superfamily zYEb#*Kar =a 6e*f 4.antigen-presenting cell (APC) 7Mb-v} u-=VrHff^* 5.death domain 3K%_wCZ
COcS
w 6.CCR and CXCR Hl
z$@[$ OE2r2ad 7.Lectin (or mitogen) @;Xa&* c3N,P<# 8.Clusters of differentiation, CD) o)M<^b3KO Nuaq{cl 9.B7 family (/C
8\}Ox #0c;2
}D 10.Cytotoxic T lymphocyte, CTL) Tua#~.3}J eV\VR
!!i 11.IL-15 and IL-15 receptor (IL-15R) Q1P=A:*]9 7w.9PNhy 12.MHC restriction .Ix[&+LsY ORhvo,.u 13.Affinity-chromatography :_pn| vA*Q}]Ov 14.Cyctosprin A, CsA s ?|Hw|j c:2LG_mQ 15.Antibody-dependent cell-mediated cytotoxicity, ADCC) "ed
A okH*2F(- ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© ?D=C8[NEX @k\npFKQm 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 d8&T62Dnd4 ZC
3;QKw> 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ mJ+mTA5
bW {11xjvAD 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 =a(]@8$!1 w/@ tH Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© gq050Bl) uuYeXI; ÃâÒßѧרҵ£º 6@I
r|o d bHxc@H 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ &[_D'jm+S0 64t: Ïû»¯ÄÚ¿Æ£º 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ a=M/0N{! 4c@_u8 ѪҺ²¡Ñ§×¨Òµ£º 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
K1zH\wH "-g5$v$de Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ (רҵ»ù´¡: ÃâÒßѧ) bkiMF$K,K 6\xfoy|j
Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö) jz,Gj}3; SDko# 1. ADCC(antibody dependent cell-mediated cytotoxicity) $.3J1DU S+GW}?! 2. »·æß¾úËØ(cyclosporin) 3 V$
\s8 afd.v$63 3. KIR(killer cell inhibitory receptor) lA n^)EL vCn\_Nu;W& 4. HLDA(human leucocyte differentiation antigen) d Y`P [@/s! i @ 5. Interleukin 18(IL-18) {~ 1
~V &<t`EI];)4 6. ÕûºÏËØ(integrin) lfqsoIn; p%IVWeZnx 7. Fas/FasL yZ,S$tSR ksF4m_E>YB 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå) Vn?|\3KY .cB>ab& 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
scZ&}Ni fK+[r1^ 10. Th1/Th2 CmdPa!4) CIA
KXYM 11. »ùÒòÒßÃç(DNAÒßÃç) 1aoKf F( v-}B
T+ 12. chemokines and chemokine receptor $LOf2 kn /`g~lww2O 13. ÃâÒßÄÍÊÜ =Q4Wr0y><] CQ'4 ".7 14. ¹²´Ì¼¤·Ö×Ó 0xUn#&A~ !}=#h8fv 15. ËÀÍö½á¹¹Óò(death domain) T 2Gscey (} Y|^uM, ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö) U[NQ" ;ApldoMi 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉË°Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬? V@\A<q%jTs O[
z-K K< 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»Æƶø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óᣠ4\m#:fj % mw~$;64;a £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î XRXQ
7\n [k60=$y £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨ OD).kP}s^ b;"Z`/h £¨3£©1984Ä꣺ÁÜ°Íϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå Sb?HRoe_ AP0z~e £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹ 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄЩÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£ )u.%ycfeV W.?EjEx Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ) ÎÊ´ðÌâ(ÿÌâ25·Ö) BP8jReX^ OVEQ^\Q5D 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£ 5N$O sH :_sOV* 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿ yXCJ? "2hs=^&8 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆһϵͳʵÑé,¼ÓÒÔ֤ʵ¡£ 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃÇ°¾°¡£
|
|